Are you a Bronze, Silver, or Gold Member? This course is included in your membership. Take Course Now >
Dr. Rouzier reviews the levels necessary to achieve symptom improvement, the levels that were measured when symptoms return, and the time frame from symptom resolution and the subsequent return of symptoms. Dr. Rouzier shares two papers that can be given to patients demonstrating that only supraphysiologic levels result in symptom improvement. The series on Testosterone in Women will address that the goals in woman are different and focus on improvement in quality of life and well-being and not on unscientific numbers or lab tests.
Objectives:
Upon completion of this workshop, the healthcare professional will be able to:
- Discuss recent literature demonstrating that symptom improvement is woman requires high, supraphysiologic levels of testosterone.
- Discuss opinion papers (Not RCT) that recommend maintaining testosterone levels within the “normal” range of >75 ng/ml, however, there is lack of any scientific support for any benefit for maintaining levels within the normal range.
- Describe contrasting medical studies and recommendations documenting that symptom improvement can only be achieved by supraphysiologic levels of testosterone that requires supraphysiologic dosing to achieve symptom improvement.
- Compare and contrast the different opinions and guidelines by various “experts” that differ considerably.
- Recall that some authors recommend restricting the use of testosterone in women whereas others recommend replacement in all women that are symptomatic of testosterone deficiency.
- Associate that a trial of testosterone should be administered to symptomatic women and that is should be continued if symptomatic improvement occurs.
- Discuss the current recommendations to treat women based on symptoms and not serum levels.
- Identify guidelines that recommend not testing or following serum levels.
